DALLAS, May 16, 2014 /PRNewswire-iReach/ -- "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines". The report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure in the country. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.
The Philippines' pharmaceutical market value will increase from $4.3 billion in 2013 to $8 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.4%. According to the company's latest report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines", the Philippines have the third largest pharma market among the countries in the Association of Southeast Asian Nations (ASEAN), just after Indonesia and Thailand.
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=176877 .
"Although an increasing disease burden, coupled with prevailing high pharmaceutical prices, are providing the necessary investment incentives for the healthcare market in the Philippines, limited access to healthcare facilities and governmental cuts could yet impede further growth in the future."
Furthermore, public health insurance provider Philippine Health Insurance Corporation does not cover the country's entire population, resulting in the majority of people being unable to afford medicines. "The government has taken a number of measures to control the high drug prices to very little effect, thanks to the large amount of imported therapies and the demand for costly branded drugs."Additionally, high spending to overcome basic economic concerns, such as poverty, dependence on imports and high external debt, have left the Philippines' government with insufficient funds to finance the development of healthcare infrastructure.
This report provides information and analysis on the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies key trends in the Philippines' healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure.
The Report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines" is available at http://www.rnrmarketresearch.com/countryfocus-healthcare-regulatory-and-reimbursement-landscape-philippines-market-report.html .
The positive trend in the healthcare market of the Philippines can be attributed primarily to the following factors -
-- Generic substitution in both the public and private sectors, which has been a driver for the manufacture of generic drugs -- Increased expenditure on medicines by Local Government Units (LGUs) -- Government initiatives for the prevention and management of chronic diseases -- An improved and updated regulatory environment
This report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, including the following -
-- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers -- Profiles and SWOT analyses for major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck) -- An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices -- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure -- An overview of the opportunities for and challenges facing growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
-- Develop business strategies based on a sound understanding of the trends shaping and driving the healthcare market in the Philippines -- Generate revenue based upon knowledge of key trends, reimbursement and regulatory policies, pharmaceutical market segments, and the companies likely to impact the healthcare market in the future -- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors -- Organize sales and marketing efforts by identifying the market categories and segments that present the greatest opportunities for consolidation, investment, and strategic partnership -- Identify, understand, and capitalize upon the opportunities and challenges in the Philippines' healthcare market
Browse more reports on Healthcare Industry at http://www.rnrmarketresearch.com/reports/life-sciences/healthcare .
RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers. Call with your research requirements or email the details on email@example.com This e-mail address is being protected from spambots.
Media Contact: Priyank Tiwari, RnRMarketResearch, +18883915441, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com